The Opportunity: We are currently recruiting for an experienced, dynamic and visionary Senior Director of Cardiovascular & Renal Global Commercial Development to join our team. This pivotal role will serve as the commercial voice within the R&D Product Strategy Team (PST), driving Early Product Strategy, Target Product Profiles & Claims (TPPs/TPCs), Market Shaping, Product Positioning, Stakeholder Engagement, Stage-Gate Preparation, Value Proposition and Life Cycle Management (LCM) Planning and Execution across multiple indications. The successful candidate will contribute to the therapeutic area (TA) strategy and execution to maximize long-term asset value, optimize portfolio balance, and identify opportunities for inorganic growth. The Role: Commercial Leadership: Define the commercial direction for a new MOA and new disease areas at CSL. Lead a co-development/co-promotion cross-company partnership. Act as the primary commercial representative in the R&D Product Strategy Team (PST), influencing early product strategy, TPPs, TPCs, Stage-Gate Preparation, and LCM Planning and Execution. Product Strategy and Execution: Lead the development and execution of the multi-indication Product Strategy to drive long-term asset value and optimize product profile. Drive cross-indication accountability and leadership. Inorganic Growth: Lead cross-functional assessments of prioritized indications, assets, technologies and MOA’s from the external environment, identifying and evaluating these opportunities for inorganic growth, including partnerships, acquisitions, and collaborations. Conduct data-driven commercial diligence and drive successful business development financial cases. Cross-Functional Collaboration: Collaborate with functional and regional partners (e.g., Market Access, Insights and Analytics, US and International) to present a unified commercial voice in PSTs, TALTs, and other teams, influencing strategy and investment decisions. Deliver a positive impact on portfolio investment and resource allocation decisions. Portfolio Optimization: Influence on overall CVR strategy and future asset value creation. Drive multi-indication accountability and leadership. Ensure a balanced portfolio by managing assets across various disease areas and risk profiles, leveraging both internal and external opportunities. Drive cross-indication accountability and leadership. Strategic Influence: Define and drive the asset strategy, ensuring alignment with overall business objectives and market needs. Skills and Experience: Advanced degree in Business, Life Sciences, or a related field. 15 years of experience in commercial development, strategy and/or analytics within the pharmaceutical or biotechnology industry, specifically in Cardiology and/or Nephrology. Proven track record of leading cross-functional teams and driving strategic initiatives. Strong analytical and strategic thinking skills, with the ability to influence and drive decision-making. Expertise in leading commercial assessments of external opportunities with prior experience in BDL/M&A, analytics, consulting and/or commercial strategy. Excellent communication and collaboration skills, with the ability to work effectively with global teams.5c143e31-5e48-4549-b638-05792d185386